Searched for
EVISTA
Aurobindo Pharma gains on USFDA approval for generic osteoporosis drugShares of Aurobindo Pharma gained 3.3 per cent in trade on Monday, after the company got US FDA nod for generic osteoporosis drug.- Aurobindo Pharma gets US FDA nod for generic osteoporosis drugAurobindo Pharma has received approval from the US FDA to manufacture and market its generic version of Eli Lilly's Evista tablets used to ...
- Deal corner: Printland raises Rs 5 crore from SIDBIThe firm, which earned Rs 4 crore revenue in its first year of operations, expects to earn Rs 12 crore in fiscal 2014.
- Daiichi sets up firm to market Ranbaxy products in JapanRanbaxy’s Japanese parent Daiichi Sankyo has set up a new firm, Daiichi Sankyo Espha Company (DSECL) for marketing generic drugs in Japan.
- Ranbaxy to market Daiichi's products in RomaniaDrug firm Ranbaxy Laboratories today said its Romanian arm will market Daiichi Sankyo's drug Evista, used in treatment of osteoporosis, in ...
- Ranbaxy Lab's Romania unit to market osteoporosis drugPharma firm Ranbaxy Laboratories said its Romanian arm will market Evista, a drug used for treating osteoporosis.
Load More- Daiichi sets up firm to market Ranbaxy products in Japan